CCEL - Cryo-Cell International, Inc. Stock Analysis | Stock Taper
Logo

About Cryo-Cell International, Inc.

https://www.cryo-cell.com

Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use.

David I. Portnoy

CEO

David I. Portnoy

Compensation Summary
(Year 2024)

Salary $721,632
Bonus $750,000
Option Awards $412,721
Total Compensation $1,884,353
Industry Medical - Care Facilities
Sector Healthcare
Went public April 4, 1994
Method of going public SPAC
Full time employees 82

ETFs Holding This Stock

Summary

Total 12

Showing Top 2 of 12

Ratings Snapshot

Rating : C

Discounted Cash Flow 3
Return On Equity 1
Return On Assets 3
Debt To Equity 1
Price To Earnings 1
Price To Book 1
Overall Score 2

Most Recent Analyst Grades

Grade Summary

Hold 1

Showing Top 1 of 1

Price Target

Target High $8.5
Target Low $8.5
Target Median $8.5
Target Consensus $8.5

Institutional Ownership